Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Chelsea initiates phase II droxidopa trial in fibromyalgia

Jan. 29, 2009

Cripto blockade enhances embryonic stem cell transplant in Parkinson's disease model

Jan. 29, 2009

Lipoic acid slows Alzheimer's disease progression

Jan. 29, 2009

Addex announces successful completion of phase I program of ADX-48621

Jan. 28, 2009

Orexo and NovaMed sign licensing and distribution agreement for Abstral in China

Jan. 28, 2009

MHRA grants approval to Cortex to initiate study of CX-1739 in sleep apnea

Jan. 28, 2009

GSK-3beta inhibition with CU-GTSM improves cognitive function in Alzheimer's disease model

Jan. 28, 2009

CLK-1 inhibition may explain the effect of clioquinol in neurodegenerative diseases

Jan. 28, 2009

EpiCept reports positive results from phase IIb EpiCept trial

Jan. 28, 2009

MAP completes patient enrollment in phase III clinical trial of MAP-0004

Jan. 27, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 7, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Development and characterization of anti-CD19 in vivo CAR T therapy
BioWorld Science
Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.